CGEM Prakiraan wutah bathi resik saben saham kanggo taun ngarep cullinanoncology.com

Logo korporat perusahaan Cullinan Corp (CGEM)

Cullinan Therapeutics (CGEM) is recognized as an expert in precision oncology, developing high-precision methods for combating tumors. The company actively acquires promising molecules, integrating new platforms into its R&D processes. The primary drivers are the drug CLN-978 for autoimmune therapy and a substantial liquidity reserve. The projected growth of earnings per share for year n+1 demonstrates the issuer's resilience, while the 30.60 level captures the current state.

CGEM: Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Cullinan Oncology 04.07.2022 - 17.11.2026

Rincian metrik keuangan lan pasar Cullinan Therapeutics, Inc. (CGEM)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:Cullinan Therapeutics, Inc., CGEM
Produk merek cullinanoncology.com

To assess the asset quality of Cullinan Therapeutics (CGEM), it is critical to track the consensus forecasts of the professional community. By analyzing the outlook for EPS changes next year, an investor can see the aggregated trend of expected net income per share, which is adjusted daily. For a biotech company utilizing AI-driven molecule design, this indicator reflects market confidence in the accelerated commercialization of drugs. A positive trend confirms the effectiveness of the innovative development model and the growth of capital value.

Perusahaan pesaing

GMAB (Genmab Corp) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep exelixis.com|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Nuvalent (NUVL)|KYMR (Kymera) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep IDYA (IDEAYA Biosciences Inc)|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Enliven Pharma|ORIC Pharmaceuticals Inc - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Relay Therapeutics, Inc.|NRIX (Nurix Therapeutics) - Prakiraan wutah bathi saben saham kanggo taun ngarep|TYRA: Proyeksi tambahing bathi saben saham ing taun ngarep|VSTM (verastem.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Monte Rosa Tx GLUE|Prakiraan wutah bathi kanggo taun ngarep IMRX|C4 Therapeutics - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Black Diamond Therapeutics - Prakiraan wutah bathi saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep RPTX|PMVP: Prakiraan wutah bathi saben saham kanggo taun ngarep|karyopharm.com - Proyeksi tambahing bathi saben saham ing taun ngarep|PPCB: Prakiraan wutah bathi kanggo taun ngarep|Bio Green Med Solution Inc - Dinamika bathi saben saham sing diarepake ing taun ngarep|AADI (Aadi Bioscience Inc) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep aileronrx.com ALRN|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Blueprint Medicines Corp. (BPMC)|GLYC (GlycoMimetics) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep SWTX (SpringWorks Therapeutics, Inc)